Sordillo, P P <br/><br/>
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma.  [electronic resource] 

 -  American journal of clinical oncology  Jun 1982 
 - 273-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0277-3732 
<br/><br/><label>Standard No.: </label>10.1097/00000421-198206000-00006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Aminoacridines--adverse effects<br/>Amsacrine<br/>Anemia--chemically induced<br/>Antineoplastic Agents--therapeutic use<br/>Drug Evaluation<br/>Humans<br/>Leukopenia--chemically induced<br/>Stomach Neoplasms--drug therapy